The store will not work correctly when cookies are disabled.
We use cookies to make your experience better.To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
To be used in conjunction with Cayman’s TP receptor (mouse) Polyclonal Antibody (Item No. ) to block protein-antibody complex formation during analysis for the TP receptor Thromboxane A2 (TXA2) is a potent vasoconstrictor and activator of platelet aggregation. The short half-life of TXA2 ensures local action whether generated by vascular endothelial cells or by platelets and confers physiologically beneficial or deleterious effects under inflammatory situations., TXA2 elicits its effects via a 7-transmembrane domain G-protein coupled receptor, the TP receptor. This receptor can also bind prostaglandin H2 and isoprostanes and was first cloned from human placenta and the platelet-like MEG-01 cell line., The TP receptor is highly expressed in platelets and is relatively less abundant in tissues such as lung, kidney, brain, spleen, thymus, monocytes, uterus, and placenta.,,, The apparent molecular weight for TP receptors has been reported from 37 to 70 kDa, depending on different degrees of glycosylation,,, however Cayman’s antibody consistently detects the TP receptor at 55 and 64 kDa in platelet, kidney and COS-7 cell samples.
WARNING This product is not for human or veterinary use.
Technical Information
Synonyms
Thromboxane A2 Receptor
TXA2 Receptor
Amino Acids
amino acids 275-289 (VMSFSGQLLRATEHQ)
Formulation
200 µg of peptide in 200 µl TBS, pH 7.4, containing 0.1% BSA and 0.02% sodium azide